Posted by Michael Wonder on 26 Jan 2023
Evolus receives regulatory approval for Nuceiva in Australia
23 January 2023 - Australia among the largest countries in the world for aesthetic neurotoxins.
Evolus today announced that the Australian TGA has provided regulatory approval for Nuceiva (prabotulinumtoxinA), a neurotoxin dedicated exclusively to aesthetics.
